Hisataka Moriwaki
- Hepatology top 0.1%
- Liver Disease and Transplantation 54
- Liver physiology and pathology 26
- Biochemistry top 0.2%
- Biological Psychiatry top 0.5%
- Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment 94
- Hepatitis B Virus Studies 24
-
- Retinoids in leukemia and cellular processes 70
-
- Lymphoma Diagnosis and Treatment 34
-
- Cancer Research and Treatments 26
-
- Gallbladder and Bile Duct Disorders 25
- Co-authors
- Masahito ShimizuMasahito NagakiHisashi TsurumiAtsushi SuetsuguTakuji TanakaYasutoshi MutoIchiro YasudaMakoto Shiraki
- Journals
- Cell (1 paper)Journal of Biological Chemistry (5 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hisataka Moriwaki
501 papers receiving 16.3k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Hepatology 3.8k
- Biochemistry 1.3k
- Applied Microbiology and Biotechnology 404
- Biological Psychiatry 425
- Epidemiology 4.4k
Countries citing papers authored by Hisataka Moriwaki
This map shows the geographic impact of Hisataka Moriwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisataka Moriwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisataka Moriwaki more than expected).
Fields of papers citing papers by Hisataka Moriwaki
This network shows the impact of papers produced by Hisataka Moriwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisataka Moriwaki. The network helps show where Hisataka Moriwaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hisataka Moriwaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2016 | 12 | |
| 4 | C57/BL/KSJ-db/db肥満マウスにおけるジエチルニトロソアミン誘発性肝腫瘍形成に対するアスタキサンチンの予防効果 | 2016 | 1 |
| 5 | 2012 | 26 | |
| 6 | 2012 | 32 | |
| 7 | 2010 | 49 | |
| 8 | 2008 | 28 | |
| 9 | 2007 | 7 | |
| 10 | 2004 | 2 | |
| 11 | 2001 | 1 | |
| 12 | [Hypereosinophilic syndrome with DIC treated successfully with a combination of high-dose methylprednisolone and cyclosporin A]. | 2001 | 6 |
| 13 | 2001 | 139 | |
| 14 | Liver Fibrosis and Hepatic Stellate Cells | 2000 | 2 |
| 15 | 1998 | 1 | |
| 16 | 1997 | 1 | |
| 17 | [Acute myelogenous leukemia with diabetes insipidus without desmopression administration by anti-leukemic chemotherapy]. | 1995 | 3 |
| 18 | 1990 | 2 | |
| 19 | 1988 | 1 | |
| 20 | 1980 | 1 |
About Hisataka Moriwaki
Hisataka Moriwaki is a scholar working on Hepatology, Biological Psychiatry and Cancer Research, having authored 511 papers that have together received 16.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (94 papers), Retinoids in leukemia and cellular processes (70 papers), Liver Disease and Transplantation (54 papers), Lymphoma Diagnosis and Treatment (34 papers), Liver physiology and pathology (26 papers), Cancer Research and Treatments (26 papers), Gallbladder and Bile Duct Disorders (25 papers) and Hepatitis B Virus Studies (24 papers). The work is most often cited by research in Hepatology (3.8k citations), Biochemistry (1.3k citations) and Applied Microbiology and Biotechnology (404 citations). Hisataka Moriwaki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masahito Shimizu, Masahito Nagaki, Hisashi Tsurumi, Atsushi Suetsugu, Takuji Tanaka, Yasutoshi Muto, Ichiro Yasuda, Makoto Shiraki, Yohei Shirakami and Mitsuru Seishima. Their work appears in journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.